Advertisement

Topics

Companies Related to "silencing technology gets first drug approval after year" [Most Relevant Company Matches] RSS

08:45 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "silencing technology gets first drug approval after year" found in our extensive corporate database of over 50,000 company records.

Showing "silencing technology gets first drug approval after year" Companies 1–25 of 9,900+

Relevant

BioDelivery Sciences International

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics. Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and eff...


Pharmaceutical Special Projects Group, LLC

Pharmaceutical Special Projects Group, LLC At PSPG we’re serious about the drug approval process. Not all drugs are approvable, but if yours is, you can be sure that we will move heaven and earth to give it the best and quickest route through the regulatory approval process. We have many years of experience SUCCESSFULLY getting drugs approved by regulators all over the world. We have never ha...

Pacific BioDevelopment, LLC.

Our mission at Pacific BioDevelopment is to provide the highest quality integrated drug development strategies in order to facilitate timely and cost efficient proof-of-concept results, entry into the clinic, or market approval. Our goal is to develop long term relationships with each client by providing comprehensive drug development strategies designed to accelerate time to approval. Since 1997,...


Able Labs Incorporated

Able Laboratories, Inc. is a rapidly growing developer and manufacturer of generic pharmaceuticals in tablet, capsule and suppository dosage forms. Able's focus is to develop products that offer attractive market opportunities within selected niche markets of the generic drug industry. In addition to one New Drug Application approval (NDA), the company received 13 Abbreviated New Drug Application ...

Quark Biotech, Inc.

Quark Biotech, Inc., is a biopharmaceutical company headquartered in the U.S., focused on the development of drugs based in its proprietary target genes.Quark has developed a broad technology portfolio covering fundamental drug discovery techniques as well as numerous specific disease targets. Through innovative combinations of gene silencing and DNA microarray technology, Quark has pioneered and ...

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...

The Drug & Device Development Co., Inc

The Drug & Device Development Co., Inc. founded in 1985, has expertise in the regulatory, clinical, quality and statistical aspects of drug, biologic, diagnostic, and medical device development. The DDD group consists of both full-time and part-time specialists. Each one is well experienced in one or more aspects of the drug, biologic and/or device approval process.The major focus of DDD's service...

Naryx Pharma, Inc.

Naryx Pharma is a specialty pharmaceutical company that is developing promising propriety medication formulations for the FDA approval process. Naryx Pharma is focused on development of its product candidates of inhaled, nebulized, intranasal drug formulations. The approvals will enable Naryx Pharma to market and distribute formulations that will fulfill an unmet medical need for the treatment of ...

BioTime, Inc. 

BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. The Company’s current clinical programs are targeting three primary sectors, aesthetics, ophthalmology and cell and drug delivery. Its clinical programs are based on two platform technologies: pluripotent cells...

Association of Diabetes Investigator's

We work together with the pharmaceutical industry to develop agents to improve the lives of diabetic patients. It is in our joint interest to identify promising areas for drug development and to streamline the processes leading to approval and marketing of new agents. As the lead investigators in numerous studies which have brought new drugs into common use, we have acquired a unique experie...

Sirion GmbH

SIRION offers tools and services for RNAi expression and solutions for customized adenovirus-mediated gene delivery. SIRIONs proprietary Q-tech technology enables efficient RNAi driven gene silencing without siRNA transfection.

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism pr...

Pipex

Pipex Pharmaceuticals, Inc. (“Pipex”) (OTC: BB: PPEX) is a development-stage, specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of neurologic and autoimmune diseases. Our strategy is to exclusively in-license proprietary, clinical-stage drug candidates that have demonstrated clinical efficacy and to complete the further clinical testi...

Madeira Therapeutics, LLC

Madeira Therapeutics, LLC, is a privately held, specialty pharmaceutical company focused on providing safe and effective medicine to pediatric and geriatric patients, parents and the healthcare professionals who serve them. The Madeira strategy focuses on reformulating adult drugs for better dosage control in children. Madeira utilizes the FDA’s 505(b...

GelTex Incorporated

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialy...

Medafor Inc.

Medafor is a privately held Minnesota Corporation based in Minneapolis. Medafor was founded to develop applications and markets for its patented, plant-based, flowable hemostatic powder technology. MPH(r) is a microporous, polysaccharide hemostatic agent that is engineered to rapidly dehydrate blood and accelerate clotting. Medafor received FDA approval fo...

Par Pharmaceutical

Par Pharmaceutical Companies, Inc. develops, manufactures, and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In July 2005, Par received approval for and introduced Megace® ES, the company's first branded pharmaceutical product. We expect to launch our second branded product some time in 2006. Our Generic Products Division is committed to providing high-qualit...

Dicerna Pharmaceuticals

Dicerna Pharmaceuticals is a private, venture-backed RNAi-focused biopharmaceutical company developing novel therapeutic agents and related drug delivery systems in multiple disease areas based on its proprietary Dicer Substrate Technology™ platform and Dicer Substrate siRNA (DsiRNA) molecules. Dicer Substrate Technology is a second generation RNAi ap...

Celltrion Inc.

Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacture of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EMA approval for Inflectr...

Drug Delivery Technology

In 1984, Ralph began his career in publishing as a member of the start-up team for a new magazine titled Spectroscopy which was a publication serving the analytical instrumentation market. Following its success in the United States, Ralph expanded the operation abroad and introduced Spectroscopy Europe the following year. Ralph is also credited with the introduction of BioPharm magazine and later ...

SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approva...

Camargo Pharmaceutical Services

Camargo Pharmaceutical Services is an end-to-end drug development service provider specializing in the 505(b)(2) approval pathway. Camargo works with companies to develop comprehensive programs, managing every facet of the plan from formulating and testing the drug product, to conducting clinical studies and FDA application submissions. Connect with Camarg...

BioMimetic Therapeutics, Inc.

BioMimetic Therapeutics is a biotechnology company utilizing purified recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. rhPDGF-BB is a synthetic form of one of the body's principal agents to stimulate and direct he...

Hebei Jintong Corporation of Pharmacochemicals

Hebei Jintong Corporation of Pharmacochcmicals, which is located in the Hi-tech Developing Zone of ShiJiaZhuang,HeBei,China, is one of the leading specialized manufacturer of the intermediates of cephalosporin.Since its foundation, the corporation, following its market oriented, science and technology based policy of management and development, has produced a series of new pharmic intermediates. A...

Panagin Pharmaceuticals Inc.

Panagin Pharmaceuticals Inc., a privately-held biotech company, specializes in the discovery, research, development and commercialization of saponin based anti-cancer drugs. Panagin's proprietary new drug candidates show strong anti-cancer properties against various advanced, metastatic, multi-drug resistant cancers. Panagin's research and clinical programs focus on life-threatening diseases, such...


More From BioPortfolio on "silencing technology gets first drug approval after year"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks